Novartis Bioventures Ltd Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
3
Insider Buys Sum
$15.8M
Insider Sells Quantity
15
Insider Sells Sum
$2.66M

Insider Activity of Novartis Bioventures Ltd

Biography of Novartis Bioventures Ltd

No biography is available at this moment.

2019-05-28PurchaseBicycle Therapeutics plc
BCYC
10 percent owner
337,260
5.2684%
$14.00$4.72M-13.68%
2015-07-15SaleEledon Pharmaceuticals, Inc.
ELDN
10 percent owner
3,566
0.0164%
$14.26$50,844-45.39%
2015-07-14SaleEledon Pharmaceuticals, Inc.
ELDN
10 percent owner
27,861
0.1256%
$14.41$401,477-46.4%
2015-07-13SaleEledon Pharmaceuticals, Inc.
ELDN
10 percent owner
20,611
0.0915%
$14.20$292,717-46.02%
2015-06-16SaleEledon Pharmaceuticals, Inc.
ELDN
10 percent owner
1,120
0.0051%
$14.27$15,982-30.41%
2015-06-12SaleEledon Pharmaceuticals, Inc.
ELDN
10 percent owner
5,919
0.0267%
$14.20$84,050-26.83%
2015-06-11SaleEledon Pharmaceuticals, Inc.
ELDN
10 percent owner
27,875
0.1247%
$14.20$395,825-27.3%
2015-03-19SaleEledon Pharmaceuticals, Inc.
ELDN
10 percent owner
46,141
0.208%
$14.50$669,045-21.33%
2015-03-18SaleEledon Pharmaceuticals, Inc.
ELDN
10 percent owner
3,000
0.0134%
$14.50$43,500-21.78%
2014-09-22PurchaseEledon Pharmaceuticals, Inc.
ELDN
10 percent owner
325,000
11.3951%
$15.00$4.88M-25.73%
2014-06-15SaleEledon Pharmaceuticals, Inc.
ELDN
10 percent owner
14,777
0.3747%
$14.20$209,833
2014-03-25PurchaseAkebia Therapeutics, Inc.
AKBA
10 percent owner
365,180
13.9378%
$17.00$6.21M+3.17%
2011-01-26SaleModerna, Inc.
MRNA
10 percent owner
74,500
0.0005%
$1.17$87,130
2011-01-25SaleModerna, Inc.
MRNA
10 percent owner
93,005
0.0006%
$1.12$104,567
2011-01-24SaleModerna, Inc.
MRNA
10 percent owner
72,800
0.0005%
$1.20$87,222
2011-01-21SaleModerna, Inc.
MRNA
10 percent owner
69,500
0.0005%
$1.25$87,218
2011-01-20SaleModerna, Inc.
MRNA
10 percent owner
51,400
0.0004%
$1.36$70,061
2011-01-19SaleModerna, Inc.
MRNA
10 percent owner
42,800
0.0004%
$1.53$65,419
Total: 18
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.